Abstract
The mechanisms of the renal excretion of AM-715, a synthetic antimicrobial agent, were studied in rabbits, dogs, and humans. In both rabbits and humans, AM-715 clearance was greater than creatinine clearance and was profoundly decreased by the administration of probenecid. Thus, in these subjects, AM 715 was cleared by both tubular secretion and glomerular filtration. In dogs, however, the excretion ratio (close to unity), biological half-life, and stop-flow pattern of AM-715 were not affected by probenecid, indicating that the renal excretion of AM-715 took place mostly through glomerular filtration. These results suggest that renal excretion of AM-715 differs with animal species.
Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cunningham R. F., Israili Z. H., Dayton P. G. Clinical pharmacokinetics of probenecid. Clin Pharmacokinet. 1981 Mar-Apr;6(2):135–151. doi: 10.2165/00003088-198106020-00004. [DOI] [PubMed] [Google Scholar]
- DISCHE Z., BORENFREUND E. A new spectrophotometric method for the detection and determination of keto sugars and trioses. J Biol Chem. 1951 Oct;192(2):583–587. [PubMed] [Google Scholar]
- Higashio T., Abe Y., Yamamoto K. Renal effects of bumetanide. J Pharmacol Exp Ther. 1978 Oct;207(1):212–220. [PubMed] [Google Scholar]
- Hirai K., Ito A., Abe Y., Suzue S., Irikura T., Inoue M., Mitsuhashi S. Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections. Antimicrob Agents Chemother. 1981 Jan;19(1):188–189. doi: 10.1128/aac.19.1.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Israel K. S., Black H. R., Nelson R. L., Brunson M. K., Nash J. F., Brier G. L., Wolney J. D. Cinoxacin: pharmacokinetics and the effect of probenecid. J Clin Pharmacol. 1978 Oct;18(10):491–499. doi: 10.1002/j.1552-4604.1978.tb01577.x. [DOI] [PubMed] [Google Scholar]
- Ito A., Hirai K., Inoue M., Koga H., Suzue S., Irikura T., Mitsuhashi S. In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrob Agents Chemother. 1980 Feb;17(2):103–108. doi: 10.1128/aac.17.2.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rodriguez N., Madsen P. O., Welling P. G. Influence of probenecid on serum levels and urinary excretion of cinoxacin. Antimicrob Agents Chemother. 1979 Mar;15(3):465–469. doi: 10.1128/aac.15.3.465. [DOI] [PMC free article] [PubMed] [Google Scholar]